Online Training - Magnifying Glass Concept.

Accreditation Renewed for Online Curriculum

The National Blood Clot Alliance announces new accreditation of the widely used, web-based online curriculum titled Stop the Clot™ – What Every Healthcare Professional Should Know.  This online curriculum about DVT/PE provides no-cost contact hours for healthcare professionals.  As a self-paced, interactive online course, it provides the most current foundational information on assessing and managing…

Treatment Adherence Compared between Nonvalvular AFib Patients Using XARELTO (rivaroxaban) and Those Using warfarin

New data from a study published online in Current Medical Research and Opinion and co-authored by researchers at Janssen Pharmaceuticals, American distributor of XARELTO® (rivaroxaban), indicate that rivaroxaban is associated with significantly greater adherence rates for patients with nonvalvular atrial fibrillation (NVAF) as compared to warfarin.  Other oral anti-coagulant medications were not included in this comparison. Medication non-adherence…

STABLE Results Warfarin Home Monitoring

Study on Home Monitoring Released

A study was recently released in the American Journal of Managed Care regarding home point-of-care international normalized ration (INR) monitoring. The study, co-authored by NBCA MASAB member Dr. Jack Ansell, documents the ability of patients to monitor their own warfarin therapy outside of a clinical trial setting.  The analysis of over 28,000 patients performing home…

Screen Shot 2014-05-14 at 1.52.46 PM

New Tool to Help Doctors Manage Anticoagulation During Invasive Procedures

A new, free-of-charge tool produced by the New York State Anticoagulation Coalition will enable clinicians to more easily determine how, whether and when to stop the use of warfarin and other anticoagulants prior to surgery and other invasive procedures ranging from major orthopedic or cancer surgery to colonoscopies and arthroscopy to dental cleanings and dermatological…

Screen Shot 2014-05-08 at 9.15.25 AM

Alere Initiates Voluntary Urgent Product Recall of Alere INRatio®2 PT/INR Professional Test Strips

Healthcare Professionals Should Stop Using Strips Contact: Consumer: 844-292-5373 Media: Jackie Lustig 781-314-4009 Jackie.Lustig@alere.com FOR IMMEDIATE RELEASE - May 6, 2014 – WALTHAM, Mass. – Alere Inc. (NYSE:ALR) has initiated a voluntary Class 1 recall in the U.S. of the Alere INRatio2 PT/INR Professional Test Strips (PN 99008G2). This action is a result of complaints of…

Aspirin and Blood Clots

What is the Role of Aspirin in Preventing Recurrent Venous Thromboembolism? For several decades, aspirin has been the mainstay of antithrombotic therapy to prevent recurrent arterial thrombotic events. Aspirin is also effective in the primary prevention of myocardial infarction, particularly in men. For the prevention of deep venous thrombosis and pulmonary embolism, anticoagulants are the…

Home Monitoring for Warfarin Therapy

The Status of INR Home Monitoring for Warfarin Therapy Warfarin has been the principal oral anticoagulant (blood thinner) in use in the United States for a variety of blood clotting (thrombotic) diseases since the 1950s. Warfarin therapy, however, has many drawbacks, principally among them, the complexity and labor intensiveness of managing therapy and the high risk of adverse events often…

PREGNANCY, BLOOD CLOTS AND ANTICOAGULATION

Pregnancy requires special consideration with respect to the prevention and treatment of blood clots. Pregnancy does not cause blood clots, but increases the chance that a blood clot will develop by four- to five-fold. Pregnancy’s tendency to form clots is an evolutionary response to protect women against the bleeding challenges of miscarriage and childbirth. In…